BYLINE BANCORP, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BYLINE BANCORP, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $130.05M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $120.76M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $107.88M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $87.95M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $92.79M | Mar 4, 2024 |
| FY2020 | Dec 31, 2020 | $12.29M | Mar 4, 2021 |
| FY2020 | Sep 30, 2020 | $13.07M | Mar 4, 2021 |
| FY2020 | Jun 30, 2020 | $9.14M | Mar 4, 2021 |
| FY2020 | Mar 31, 2020 | $2.97M | Mar 4, 2021 |
| FY2020 | Dec 31, 2019 | $15.85M | Mar 4, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.65B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $9.50B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $8.88B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $7.36B | Mar 4, 2024 |
| FY2022 | Dec 31, 2021 | $6.70B | Mar 7, 2023 |
| FY2021 | Dec 31, 2020 | $6.39B | Mar 7, 2022 |
| FY2020 | Dec 31, 2019 | $5.52B | Mar 4, 2021 |
| FY2019 | Dec 31, 2018 | $4.94B | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $3.37B | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $3.30B | Mar 30, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.38B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $8.41B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $7.89B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $6.60B | Mar 4, 2024 |
| FY2022 | Dec 31, 2021 | $5.86B | Mar 7, 2023 |
| FY2021 | Dec 31, 2020 | $5.59B | Mar 7, 2022 |
| FY2020 | Dec 31, 2019 | $4.77B | Mar 4, 2021 |
| FY2019 | Dec 31, 2018 | $4.29B | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $2.91B | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $2.91B | Mar 30, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.27B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.09B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $990.15M | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $765.82M | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | $836.38M | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | $805.46M | Mar 4, 2024 |
| FY2022 | Dec 31, 2019 | $750.12M | Mar 7, 2023 |
| FY2021 | Dec 31, 2018 | $650.67M | Mar 7, 2022 |
| FY2020 | Dec 31, 2017 | $458.58M | Mar 4, 2021 |
| FY2019 | Dec 31, 2016 | $382.66M | Mar 12, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Mar 4, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 4, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 4, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 4, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 4, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 4, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Mar 4, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 4, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 4, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 4, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 4, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 4, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $149.10M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $563.14M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $226.14M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $179.35M | Mar 4, 2024 |
| FY2022 | Dec 31, 2021 | $157.93M | Mar 7, 2023 |
| FY2021 | Dec 31, 2020 | $83.42M | Mar 7, 2022 |
| FY2020 | Dec 31, 2019 | $80.74M | Mar 4, 2021 |
| FY2019 | Dec 31, 2018 | $121.86M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $58.35M | Mar 15, 2019 |
| FY2018 | Dec 31, 2016 | $46.53M | Mar 15, 2019 |